pgl3 zscan4 promoter plasmid (Addgene inc)
Structured Review
![(A) Left: longitudinal quantitation of DUX4 and <t>ZSCAN4-tdTomato</t> containing nuclei in iDUX4 ZSCAN4-tdT reporter myoblasts at 2h intervals after DOX (62.5 ng/mL). Right: immunofluorescence micrographs of iDUX4 ZSCAN4-tdT reporter myoblasts before (0h), and 4h and 16h after exposure to DOX (62.5 ng/mL; green=DUX4, red=ZSCAN4-tdTomato, blue=nuclei; scale bar=100μm). (B) Normalised oxygen consumption rate (OCR) curves of iDUX4 control (CTRL) and DOX-induced (62.5 ng/mL DOX for 4h and 16h) myoblasts. (C) Respirometric assessment of mitochondrial respiration reveals reduction of basal, maximal and ATP-linked respiration in iDUX4 myoblasts 4h after DOX (62.5 ng/mL). (D) Normalised extracellular acidification rate (ECAR) curves of iDUX4 control (CTRL) and DOX-induced (62.5 ng/mL DOX for 4h and 16h) myoblasts. (E) ATP production rates demonstrating reduction of ATP in iDUX4 myoblasts 4h after DOX (62.5 ng/mL), mainly arising from defective oxidative phosphorylation (OXPHOS; mitoATP), while glycoATP is unaffected before 16h. (F) Assaying of Casp9 (red; onset 4h after DOX) and Casp3/7 activation (grey; onset 8h after DOX), measured at 2h intervals over 16h. (G) Assaying Annexin V as a marker of apoptosis in iDUX4 myoblasts after DOX (62.5 ng/mL), measured at 2h intervals over 16h. (H) Casp3/7 activation in iDUX4 myoblasts 8h after DOX (62.5 ng/mL) is prevented by a Casp9 inhibitor (Z-LEHD-FMK TFA; 10 μM). (I) Casp3/7 and Casp9 activation in iDUX4 myoblasts 8h after DOX (62.5 ng/mL) with non-targeted (Q10; 20 μM) or mitochondria-targeted (mitoQ10; 20μM) Coenzyme Q10. [n=3-6, data is mean ± s.d., where * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001].](https://bio-rxiv-images-cdn.bioz.com/dois_ending_with_59/10__1101_slash_2025__11__25__690559/10__1101_slash_2025__11__25__690559___F4.large.jpg)
Pgl3 Zscan4 Promoter Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pgl3+zscan4+promoter+plasmid/bio_rxiv__2025__11__25__690559-196-36-46?v=Addgene+inc
Average 93 stars, based on 1 article reviews
Images
1) Product Images from "Mitochondrial Respiratory Chain Function is crucial for Muscle Toxicity in Facioscapulohumeral Muscular Dystrophy"
Article Title: Mitochondrial Respiratory Chain Function is crucial for Muscle Toxicity in Facioscapulohumeral Muscular Dystrophy
Journal: bioRxiv
doi: 10.1101/2025.11.25.690559
Figure Legend Snippet: (A) Left: longitudinal quantitation of DUX4 and ZSCAN4-tdTomato containing nuclei in iDUX4 ZSCAN4-tdT reporter myoblasts at 2h intervals after DOX (62.5 ng/mL). Right: immunofluorescence micrographs of iDUX4 ZSCAN4-tdT reporter myoblasts before (0h), and 4h and 16h after exposure to DOX (62.5 ng/mL; green=DUX4, red=ZSCAN4-tdTomato, blue=nuclei; scale bar=100μm). (B) Normalised oxygen consumption rate (OCR) curves of iDUX4 control (CTRL) and DOX-induced (62.5 ng/mL DOX for 4h and 16h) myoblasts. (C) Respirometric assessment of mitochondrial respiration reveals reduction of basal, maximal and ATP-linked respiration in iDUX4 myoblasts 4h after DOX (62.5 ng/mL). (D) Normalised extracellular acidification rate (ECAR) curves of iDUX4 control (CTRL) and DOX-induced (62.5 ng/mL DOX for 4h and 16h) myoblasts. (E) ATP production rates demonstrating reduction of ATP in iDUX4 myoblasts 4h after DOX (62.5 ng/mL), mainly arising from defective oxidative phosphorylation (OXPHOS; mitoATP), while glycoATP is unaffected before 16h. (F) Assaying of Casp9 (red; onset 4h after DOX) and Casp3/7 activation (grey; onset 8h after DOX), measured at 2h intervals over 16h. (G) Assaying Annexin V as a marker of apoptosis in iDUX4 myoblasts after DOX (62.5 ng/mL), measured at 2h intervals over 16h. (H) Casp3/7 activation in iDUX4 myoblasts 8h after DOX (62.5 ng/mL) is prevented by a Casp9 inhibitor (Z-LEHD-FMK TFA; 10 μM). (I) Casp3/7 and Casp9 activation in iDUX4 myoblasts 8h after DOX (62.5 ng/mL) with non-targeted (Q10; 20 μM) or mitochondria-targeted (mitoQ10; 20μM) Coenzyme Q10. [n=3-6, data is mean ± s.d., where * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001].
Techniques Used: Quantitation Assay, Immunofluorescence, Control, Phospho-proteomics, Activation Assay, Marker
Figure Legend Snippet: (A) Workflow for generation of ρ 0 -like iDUX4 myoblasts: cells were treated with ethidium bromide (50, 100 or 150 nM EtBr) for two weeks, yielding ρ 0 -like iDUX4 cells with varying degrees of OXPHOS impairment (iDUX4-ρ 0+ : mild OXPHOS reduction, iDUX4-ρ 0++ : severe OXPHOS reduction and iDUX4-ρ 0+++ : full OXPHOS inhibition). Scheme was created with BioRender.com . (B) Percentage of OXPHOS versus glycolytic ATP production rate in iDUX4-ρ 0 myoblasts, with mitoATP and glycoATP production rates indicated, as determined by Seahorse respirometry. (C) Immunofluorescence (green=DUX4, blue=nuclei; scale bar=100μm) with percentage of DUX4-positive nuclei of unmodified iDUX4 and iDUX4- ρ 0+++ myoblasts after DOX (62.5 ng/mL) for 16h. (D) Expression levels of DUX4 target genes ZSCAN4 , PRAMEF1 and TRIM43 , as assessed by RT-qPCR (relative to housekeeper RPLP0 ). (E) DUX4-induced increases in mitoROS and ΔΨm in unmodified iDUX4 cells are not observed in iDUX4- ρ 0+++ myoblasts after DOX (62.5 ng/mL) for 16h. (F) DUX4-induced Casp9 activation in unmodified iDUX4 myoblasts does not occur in iDUX4- ρ 0+++ cells after DOX (62.5 ng/mL) for 8h. (G) Annexin V and Casp3/7 activation in iDUX4, iDUX4-ρ 0+ , iDUX4-ρ 0++ and iDUX4-ρ 0+++ myoblasts after DOX (62.5 ng/mL) for 36h shows inverse correlation between DUX4-induced apoptosis and mitochondrial respiratory chain impairment. DUX4 is unable to induce apoptosis in fully OXPHOS-deficient iDUX4-ρ 0+++ myoblasts. (H) Both non-DUX4-induced iDUX4 and iDUX4-ρ 0+++ myoblasts undergo apoptosis (Annexin V) after exposure to the apoptosis inducer staurosporine (STSP; 1 μM) for 48h. [n=3-12, data is mean ± s.d., where * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001].
Techniques Used: Inhibition, Immunofluorescence, Expressing, Quantitative RT-PCR, Activation Assay
